Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hCG Priming Prior to COH in Poor Responder IVF Patients
NCT00870025Phase 4Completed
- Sponsor
- International Vaccine Institute
- Start
- Oct 2008
- Primary completion
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of human chorionic gonadotropin in poor ovarian response (POR), sponsored by International Vaccine Institute. Started Oct 2008; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on NCT00870025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00870025.